Form 4 for TNGX Tango Therapeutics, Inc.

Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0000950170-24-070875 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DT	2024-06-07	2024-06-05	TNGX	Calhoun Lesley Ann	Dir	A - Grant	$0.00	+6,250	11.2K	+125%	$0
DT	2024-06-07	2024-06-05	TNGX	Calhoun Lesley Ann	Dir	S - Sale	$7.21	+5,000	6,250	+400%	+$36.0K
DT	2024-06-07	2024-06-05	TNGX	Calhoun Lesley Ann	Dir	A - Grant	$0.00	+37.5K	37.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-06-05	A	A	6,250	$0.00	11,250	D	—	—	(F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
2	Common	Common Stock	2024-06-05	S	A	5,000	$7.21	6,250	D	—	—	(F3) Represents the weighted average sales price per share. The shares sold at prices ranging from $7.01 to $7.38 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
3	Derivative	Stock Option (Right to Buy)	2024-06-05	A	A	37,500	$0.00	37,500	D	$7.41 · — to 2034-06-05	37,500 Common Stock	(F4) This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.